Discussion Gastric Cancer LBA 4002, abstracts 4003, ppt download
Major Pivotal Phase III Trials for Adjuvant Treatments of Gastric Cancer | Download Table
Chemotherapy Options for Gastric Cancer | PPT
The role of oxaliplatin in the adjuvant setting of different Lauren's type of gastric adenocarcinoma after D2 gastrectomy: a real-world study | Gastric Cancer
Cancers | Free Full-Text | Efficacy of S-1 or Capecitabine Plus Oxaliplatin Adjuvant Chemotherapy for Stage II or III Gastric Cancer after Curative Gastrectomy: A Systematic Review and Meta-Analysis
ADJUVANT CAPECITABINE AND OXALIPLATIN FOR GASTRIC CANCER AFTER D2 GASTRECTOMY (CLASSIC): A PHASE 3 OPEN-LABEL,RANDOMISED CONTROLLED TRIAL Yung-Jue Bang*, - ppt download
Role of chemotherapy in carcinoma stomach | PPT
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. | Semantic Scholar
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial - ScienceDirect
Clinical biomarkers in adjuvant chemotherapy for gastric cancer after D2 dissection by a pooled analysis of individual patient data from large randomized controlled trials | Gastric Cancer
Early stage gastric adenocarcinoma: clinical and molecular landscapes | Nature Reviews Clinical Oncology
Complete mesogastric excision for locally advanced gastric cancer: short-term outcomes of a randomized clinical trial: Cell Reports Medicine
Frontiers | VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2 ...
Practice-changing Evidence in Treatment of Noncolorectal GI Cancers - The ASCO Post
RECENT ADVANCES IN COMBINATION CHEMOTHERAPY: METASTATIC COLON CANCER
Gastrointestinal cancers: new standards of care from landmark trials | MDedge Hematology and Oncology
LANDMARK CHEMOTHERAPY AND RADIATION TRIALS IN GASTRIC CANCER.pptx
Current trends in perioperative treatment of resectable gastric cancer
Cancers | Free Full-Text | Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN)
Cancers | Free Full-Text | The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer
XELOX May Improve Survival in Gastric Cancer - CancerConnect
Survival outcomes of adjuvant taxanes, platinum plus fluoropyrimidines versus platinum and fluoropyrimidines for gastric cancer patients after D2 gastrectomy: a retrospective propensity score-matched analysis | World Journal of Surgical Oncology | Full
![PDF] Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d9216d8354645fd412b4f8534b34fefb4214d05f/4-Figure1-1.png "PDF] Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial | Semantic Scholar")
PDF] Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial | Semantic Scholar
Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial | British Journal of Cancer
